sIL 2R Human

Interleukin-2 alpha Soluble Receptor Human Recombinant
Cat. No.
BT18767
Source
Escherichia Coli.
Synonyms
CD25, IL2R, TCGFR, IL-2RA, sIL-2RA, TAC antigen, sIL-2R, IDDM10, p55.
Appearance
Sterile colorless liquid formulation.
Purity

Greater than 95.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Interleukin-2R Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 192 amino acids (22-213) corresponding to the mature IL2-R protein with an amino terminal hexahistidine tag.
The IL-2R is purified by proprietary chromatographic techniques.

Product Specs

Introduction
IL2-Ra, a subunit of the IL2 receptor, is released into the bloodstream following increased expression on cells like activated B and T cells. Elevated IL2-Ra levels are associated with autoimmune disorders, leukemias, and lymphomas.
Description
This recombinant human IL-2R protein is produced in E. coli. It is a single, non-glycosylated polypeptide chain of 192 amino acids (22-213) that corresponds to the mature IL2-R protein. It also includes an N-terminal hexahistidine tag for purification using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless liquid.
Formulation
The IL-2R His-Tag protein is supplied in a solution of 1x PBS (phosphate-buffered saline) and 50% glycerol at a pH of 7.4.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freeze the product at -20°C. Avoid repeated freeze-thaw cycles.
Purity
The purity is greater than 95.0% as determined by SDS-PAGE analysis.
Synonyms
CD25, IL2R, TCGFR, IL-2RA, sIL-2RA, TAC antigen, sIL-2R, IDDM10, p55.
Source
Escherichia Coli.

Product Science Overview

Introduction

Interleukin-2 (IL-2) is a cytokine that plays a crucial role in the immune system by promoting the growth, differentiation, and survival of certain immune cells, including T cells and B cells. The Interleukin-2 receptor (IL-2R) is a heterotrimeric protein complex composed of three subunits: alpha (IL-2Rα or CD25), beta (IL-2Rβ), and gamma (IL-2Rγ). The alpha subunit, also known as CD25, is particularly important for the high-affinity binding of IL-2.

Soluble IL-2 Receptor Alpha (sIL-2Rα)

The soluble form of the IL-2 receptor alpha (sIL-2Rα) is a truncated version of the membrane-bound receptor that is released into the bloodstream. This soluble receptor can bind to IL-2, modulating its availability and activity in the immune system. Elevated levels of sIL-2Rα are often associated with various autoimmune diseases, infections, and certain types of cancer, making it a valuable biomarker for these conditions.

Human Recombinant sIL-2Rα

Human recombinant sIL-2Rα is a laboratory-produced version of the soluble IL-2 receptor alpha. It is typically produced using recombinant DNA technology, where the gene encoding the human IL-2Rα is inserted into an expression system, such as Escherichia coli (E. coli) or Chinese Hamster Ovary (CHO) cells. The recombinant protein is then purified for use in research and clinical applications.

Production and Purification

The production of human recombinant sIL-2Rα involves several steps:

  1. Gene Cloning: The gene encoding IL-2Rα is cloned into a suitable expression vector.
  2. Expression: The vector is introduced into an expression system (e.g., E. coli or CHO cells), where the protein is produced.
  3. Purification: The recombinant protein is purified using chromatographic techniques to achieve high purity levels (typically ≥ 95% by SDS-PAGE) and low endotoxin levels (<1 EU/µg).
Applications

Human recombinant sIL-2Rα has several important applications:

  • Research: It is used in various immunological assays to study the role of IL-2 and its receptor in the immune system.
  • Clinical Diagnostics: Elevated levels of sIL-2Rα in the blood can be used as a biomarker for diagnosing and monitoring autoimmune diseases, infections, and cancers.
  • Therapeutics: Recombinant sIL-2Rα can be used in therapeutic applications to modulate the immune response, particularly in conditions where IL-2 activity needs to be regulated.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.